RxDoctor Payments Data

Katherine Bowes, PA

Physician Assistant · Westminster, MDNPI 1508082181

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 339 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,658in general payments, 2019–2025

Across 339 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • Novartis$663
  • Lilly USA, LLC$617
  • UCB, Inc.$390
  • E.r. Squibb & Sons, L.L.C.$383
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,00590%
  • Education$65410%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,658 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland →

Medicare billing

Part B allowed, 2024
$196,655
Medicare patients
734
Services billed
3,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab11$74,399
Fluorouracil107$5,419
Ketoconazole255$4,835
Clobetasol Propionate52$2,987
Tretinoin21$2,090
Metronidazole27$1,558
Azelaic Acid11$734
Triamcinolone Acetonide90$684
Doxycycline Hyclate29$600
Clindamycin Phosphate14$538
Ammonium Lactate39$523
Nystatin25$516
Mupirocin27$204
ValacyclovirValacyclovir Hcl16$195
Cephalexin16$70

Paid to pharmacies, not to this prescriber.

Other physician assistant in Westminster

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →